{"title":"A Case of Screening Macroprolactinemia Using Polyethylene Glycol Precipitation Method.","authors":"Gangfeng Li, Ningping Shan, Qian Wang","doi":"10.7754/Clin.Lab.2024.241008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated levels of prolactin (PRL) in the serum. Macroprolactinemia refers to the condition where more than 60% of the prolactin circulating in the peripheral blood is composed of high molecular weight macroprolactins. These macroprolactins typically have low biological activity but can lead to a false increase in serum prolactin levels.</p><p><strong>Methods: </strong>We report a case of pseudoelevation of prolactin caused by macroprolactin. We used pituitary MRI and other examinations to identify the cause of elevated serum prolactin levels and different detection platforms and polyethylene glycol (PEG) precipitation method to screen for the possibility of pseudo elevation of prolactin caused by macroprolactin.</p><p><strong>Results: </strong>Whether measured using two different testing platforms or using our own testing platform after sample pretreatment with PEG, serum prolactin levels were within the normal range. Therefore, based on the negative results of pituitary MRI, we believe that the patient's pseudo elevation of serum prolactin is caused by interference from macroprolactin.</p><p><strong>Conclusions: </strong>When there is an abnormal increase in serum prolactin but no evidence of related clinical symptoms, staff should consider the possibility of macroprolactin interfering with prolactin testing, take corresponding corrective measures, and avoid unnecessary examinations and treatments for patients.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 3","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated levels of prolactin (PRL) in the serum. Macroprolactinemia refers to the condition where more than 60% of the prolactin circulating in the peripheral blood is composed of high molecular weight macroprolactins. These macroprolactins typically have low biological activity but can lead to a false increase in serum prolactin levels.
Methods: We report a case of pseudoelevation of prolactin caused by macroprolactin. We used pituitary MRI and other examinations to identify the cause of elevated serum prolactin levels and different detection platforms and polyethylene glycol (PEG) precipitation method to screen for the possibility of pseudo elevation of prolactin caused by macroprolactin.
Results: Whether measured using two different testing platforms or using our own testing platform after sample pretreatment with PEG, serum prolactin levels were within the normal range. Therefore, based on the negative results of pituitary MRI, we believe that the patient's pseudo elevation of serum prolactin is caused by interference from macroprolactin.
Conclusions: When there is an abnormal increase in serum prolactin but no evidence of related clinical symptoms, staff should consider the possibility of macroprolactin interfering with prolactin testing, take corresponding corrective measures, and avoid unnecessary examinations and treatments for patients.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.